Abstract
Liquid biopsies have made a great progress in malignant tumors research. Circulating tumor cells, circulating tumor DNA and exosomes can be regarded as biomarkers to be applied in diagnosis of epithelial ovarian cancer, monitoring progress dynamically, estimating prognosis and drug resistance in chemotherapy, which can help doctors provide patients with individual treatment to realize precision medicine in epithelial ovarian cancer. Key words: Ovarian neoplasms; Liquid biopsy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
